Previous 10 | Next 10 |
home / stock / bvnry / bvnry news
GAITHERSBURG, Md., Feb. 15, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) today announced that it has entered into an agreement to sell its travel health business to Bavarian Nordic (BVNRY) for a total value of up to $380 million, including potential future milestone payments. Under ...
Bavarian Nordic A/S ( OTCPK:BVNRY ) ( OTCPK:BVNKF ) announced a new agreement with the U.S. Department of Defense’s Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense, for the advanced development of MVA-BN WEV, a prophylactic va...
Cases of monkeypox in the US have been on a steady decline since peaking in August, CDC data shows. As of Oct. 26, the 7-day moving average of daily cases was 30. That's down from a 7-day moving average peak of 446 on August 7. As of Oct. 26, HHS' Administration for Strategi...
Bavarian Nordic ( OTCPK:BVNRY ) ( OTCPK:BVNKF ) ( BAVN ) said it its COVID-19 booster vaccine ABNCoV2 showed durable antibody response six months after vaccination in a phase 2 trial. The company noted that previously reported results from the study showed,...
Bavarian Nordic ( OTCPK:BVNRY ) ( OTCPK:BVNKF ) ( BAVN ) said it signed a revised contract with the Public Health Agency of Canada (PHAC) to supply doses of smallpox/monkeypox vaccine Imvamune worth US$234M in addition to $180M in contract options. This ...
More than 540K doses of Bavarian Nordic's ( OTCPK:BVNKF ) ( OTCPK:BVNRY ) monkeypox vaccine Jynneos has been administered in the United States, according to CDC data . However, the data also shows that the total number of doses administered per week has been declining si...
Summary Bearish sentiment weighed heavily on the biotech industry and Bavarian Nordic A/S. There is reason for optimism given the current opportunities offered by Monkeypox, Ebola and Covid-19. The company is preparing for a new era of high-risk tropical infections and coronav...
Summary Bavarian Nordic will work to reach its guidance of between DKK 2.7 billion- DKK 2.9 billion ($359.8 million- $386.4 million) for the Fiscal Year 2022. I think that Bavarian Nordic's manufacturing expansion came as an afterthought as opposed to a proactive agenda that shoul...
Human-to-human transmission of monkeypox can be eliminated in Europe, but only if efforts are stepped up, according to a senior WHO official. Speaking at a press briefing today, WHO Regional Director for Europe Hans Kluge said, "There are encouraging, early signs as evidenced in F...
Bavarian Nordic A/S (BVNKF) Q2 2022 Earnings Conference Call August 24, 2022 8:00 AM ET Company Participants Rolf Sass – Investor Relations Paul Chaplin – President and Chief Executive Officer Henrik Juuel – Executive Vice President Con...
News, Short Squeeze, Breakout and More Instantly...
Bavarian Nordic A/S ADR Company Name:
BVNRY Stock Symbol:
OTCMKTS Market:
Epiroc AB ADR (EPOKY) is expected to report for Q3 2023 Sysmex Corporation ADR (SSMXY) is expected to report for Q2 2024 Streamline Health Solutions Inc. (STRM) is expected to report for Q1 2024 Helix Biopharma Corp. (HBPCF) is expected to report for Q2 2024 Standard Chartered plc...
Greif Inc. Class A (GEF) is expected to report $1.3 for Q4 2023 Skandinaviska Enskilda Banken - Class A (SVKEF) is expected to report for Q3 2023 Yellow Corporation (YELLQ) is expected to report for Q3 2023 Epiroc AB ADR (EPOKY) is expected to report for Q3 2023 Lakeland Industrie...
Addex Therapeutics Ltd (ADXN) is expected to report $-4 for Q3 2023 Eco Wave Power Global AB (publ) (WAVE) is expected to report for quarter end 2023-09-30 AmeraMex International, Inc. (AMMX) is expected to report for Q3 2023 iClick Interactive Asia Group Limited (ICLK) is expected to...